European Archives - Page 784 of 1167 - European Medical Journal

An interview with Isabel Torres from Takeda

We met with Isabel Torres, General Manager Finland, Takeda, at eyeforpharma Barcelona 2019 to talk about where the greatest opportunities lie in value-based healthcare, as well as initiatives that Isabel has been a part of, which really go beyond the medicine.

Video-Assisted Thoracoscopic Surgery: Clinical Trial Shows Improvement Over Traditional Surgery

Lung cancer has a relatively poor prognosis, killing nearly 1.8 million people worldwide each year. A common procedure for improving remission rates is…

Using In Utero Gene Editing To Tackle Lethal Lung Disease

Targeting the mid-to-late gestation period of fetal development is an attractive means of averting deadly, and potentially irreversible, pathological…

Unpeeling the Layers of Creativity and Innovation

Creativity and innovation have been described in countless ways; the concepts mean different things to different people, but this fantastic analogy…

Lifting the curtain on patient data

How can the pharmaceutical industry lead the way in data transparency and give more patients the confidence to share their records with researchers?

So long to the sales rep? Pharma sales is changing

It has become clear that healthcare professionals don’t want to be sold to. They want to be partners with industry and be treated as such. How can the rep model evolve to stay in line with expectations?

Transjugular Intrahepatic Portosystemic Stent-Shunt (TIPSS) for Acute Variceal Bleeding: Has it Come of Age?

Despite the introduction of covered TIPSS, studies have not consistently demonstrated a survival benefit in secondary prevention…

Management of Hepatitis C in People Who Inject Drugs: Some Practical Lessons from the Frontline of the Elimination Battle

One of the critical populations in this battle to achieve elimination is people who inject drugs (PWID), who in the UK represent 85% of the hepatitis C…

EMJ Hepatology 7.1 2019

A warm welcome to all our readers to this year’s edition of EMJ Hepatology, a journal packed full of cutting-edge advancements and exciting new research.

Procedural Risk of Bleeding: Does the Management of Thrombocytopenia in Chronic Liver Disease Patients Make a Difference? A Debate

Clinical studies of the TPO-R agonist lusutrombopag included a large proportion of high-risk bleeding patients and therapy with this agent has been shown…